Arbutus Biopharma (ABUS) Net Margin Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) Net Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102,200.00 |
| Dec 31, 2025 | 37,245.00 |
| Sep 30, 2025 | -3,104.00 |
| Jun 30, 2025 | 115,157.00 |
| Mar 31, 2025 | -26,121.00 |
| Dec 31, 2024 | 90,764.00 |
| Sep 30, 2024 | 131,362.00 |
| Jun 30, 2024 | 284,330.00 |
| Mar 31, 2024 | 265,013.00 |
| Dec 31, 2023 | 34,497.00 |
| Sep 30, 2023 | 127,224.00 |
| Jun 30, 2023 | -41,175.00 |
| Mar 31, 2023 | 113,205.00 |
| Dec 31, 2022 | 110,271.00 |
| Sep 30, 2022 | -12,683.00 |
| Jun 30, 2022 | 165,732.00 |
| Mar 31, 2022 | 780,107.00 |
| Dec 31, 2021 | 11.15 Mn |
| Sep 30, 2021 | 180,576.00 |
| Jun 30, 2021 | 4.11 Mn |